XML 65 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 28, 2019
USD ($)
Dec. 29, 2018
USD ($)
Dec. 28, 2019
USD ($)
segment
Dec. 29, 2018
USD ($)
Segment Reporting [Abstract]        
Number of business units | segment     3  
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact $ 257,064 $ 244,923 $ 742,720 $ 707,670
Effect of exchange rates (3,291) (2,442) (8,072) (3,323)
Net revenues 258,970 247,356 749,987 718,284
Operating (loss) income 40,907 28,320 77,344 59,689
Effect of exchange rates 2,521 2,133 7,791 7,782
Impairment of assets and related costs 0 0 (51,220) (21,170)
Amortization 5,772 6,131 17,681 18,667
PCS2 accelerated depreciation and related costs (6,649) (4,822) (18,708) (13,203)
Gain on sale of assets 0 0 8,083 0
Restructuring and turnaround costs (7,798) (1,791) (13,582) (7,258)
European Medical Device Regulation costs (448) 0 (1,005) 0
Other 0 (1,614) 701 (2,289)
United States        
Segment Reporting Information [Line Items]        
Net revenues 167,238 157,457 485,493 452,523
Japan        
Segment Reporting Information [Line Items]        
Net revenues 19,268 17,734 55,111 52,295
Europe        
Segment Reporting Information [Line Items]        
Net revenues 40,984 40,977 115,811 119,075
Asia        
Segment Reporting Information [Line Items]        
Net revenues 29,436 29,166 88,269 89,136
Other        
Segment Reporting Information [Line Items]        
Net revenues 2,044 2,022 5,303 5,255
Service        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 5,197 4,875 15,339 13,937
Plasma products and services        
Segment Reporting Information [Line Items]        
Net revenues 141,231 131,823 406,825 373,078
Blood Center products and services        
Segment Reporting Information [Line Items]        
Net revenues 66,126 67,155 191,648 199,881
Hospital products and services        
Segment Reporting Information [Line Items]        
Net revenues 51,613 48,378 151,514 145,325
Plasma        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 120,997 112,738 348,141 318,878
Blood Center        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 85,314 84,775 246,977 248,106
Hospital        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 50,753 47,410 147,602 140,686
Operating Segments        
Segment Reporting Information [Line Items]        
Operating (loss) income 122,133 106,774 351,328 310,672
Operating Segments | Plasma        
Segment Reporting Information [Line Items]        
Operating (loss) income 59,343 47,133 169,844 133,661
Operating Segments | Blood Center        
Segment Reporting Information [Line Items]        
Operating (loss) income 42,197 41,478 121,124 121,005
Operating Segments | Hospital        
Segment Reporting Information [Line Items]        
Operating (loss) income 20,593 18,163 60,360 56,006
Corporate        
Segment Reporting Information [Line Items]        
Corporate expenses $ (63,080) $ (66,229) $ (188,363) $ (196,178)